Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Graft Failure”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableLooking for participantsNCT06512519
What this trial is testing

Second Haplo-transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableStudy completedNCT04446546
What this trial is testing

Results of Cold Stored Allografts in Vascular Access

Who this might be right for
End Stage Renal Failure on DialysisHemodialysis Access Failure
Central Hospital, Nancy, France 120
Not applicableLooking for participantsNCT06569082
What this trial is testing

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Who this might be right for
Graft FailurePoor Graft Function
NYU Langone Health 21
Testing effectiveness (Phase 2)Looking for participantsNCT07053488
What this trial is testing

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Who this might be right for
Liver DiseasesLiver CancerLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07197112
What this trial is testing

Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAcute Graft vs Host Disease
Ruijin Hospital 15
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06941350
What this trial is testing

A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
Nuwacell Biotechnologies Co., Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Not applicableStudy completedNCT01869452
What this trial is testing

Platform Therapeutic Education in Heart Failure and Coronary Disease

Who this might be right for
Heart FailureAcute Coronary SyndromeCoronary Bypass Graft Stenosis of Native Artery Graft
Resicard 555
Not applicableLooking for participantsNCT02161783
What this trial is testing

Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

Who this might be right for
Primary Graft FailureSecondary Graft Failure
Masonic Cancer Center, University of Minnesota 50
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Post-approval studies (Phase 4)Study completedNCT00510913
What this trial is testing

Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Who this might be right for
Graft RejectionKidney Transplantation
Astellas Pharma Inc 450
Not applicableStudy completedNCT00587158
What this trial is testing

Oral Paricalcitol in Kidney Transplant Recipients

Who this might be right for
Transplant; Failure, KidneyRenal Disease, End StageHyperparathyroidism, Secondary
Mayo Clinic 100
Not applicableUnknownNCT03717545
What this trial is testing

Second Transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 12
Not applicableLooking for participantsNCT06512545
What this trial is testing

Modified Second Haplo-transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 12
Not applicableNot Yet RecruitingNCT05951231
What this trial is testing

Liver Transplantation After ex Vivo Liver Perfusion

Who this might be right for
Liver Transplant; ComplicationsTransplant; Failure, LiverTransplant Dysfunction+4 more
Oslo University Hospital 22
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Not applicableStudy completedNCT01741064
What this trial is testing

Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation

Who this might be right for
Secondary HyperparathyroidismDisorder Related to Renal Transplantation
Skane University Hospital 257
Load More Results